401 related articles for article (PubMed ID: 31468288)
1. Game of thrones: immunotherapy versus molecular targeted therapy in renal cell cancer scenarios.
Cetin B; Kosar A
Int Urol Nephrol; 2019 Dec; 51(12):2107-2117. PubMed ID: 31468288
[TBL] [Abstract][Full Text] [Related]
2. Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions.
Lalani AA; McGregor BA; Albiges L; Choueiri TK; Motzer R; Powles T; Wood C; Bex A
Eur Urol; 2019 Jan; 75(1):100-110. PubMed ID: 30327274
[TBL] [Abstract][Full Text] [Related]
3. The Current and Evolving Landscape of First-Line Treatments for Advanced Renal Cell Carcinoma.
Calvo E; Porta C; Grünwald V; Escudier B
Oncologist; 2019 Mar; 24(3):338-348. PubMed ID: 30158285
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint blockade as a novel immunotherapeutic strategy for renal cell carcinoma: a review of clinical trials.
Godwin JL; Zibelman M; Plimack ER; Geynisman DM
Discov Med; 2014 Dec; 18(101):341-50. PubMed ID: 25549705
[TBL] [Abstract][Full Text] [Related]
5. Integrating Immunotherapy Into the Management of Renal Cell Carcinoma.
Zibelman M; Plimack ER
J Natl Compr Canc Netw; 2017 Jun; 15(6):841-847. PubMed ID: 28596263
[TBL] [Abstract][Full Text] [Related]
6. Check point inhibitors a new era in renal cell carcinoma treatment.
Alsharedi M; Katz H
Med Oncol; 2018 May; 35(6):85. PubMed ID: 29728867
[TBL] [Abstract][Full Text] [Related]
7. Role of immunotherapy in kidney cancer.
Nazzani S; Bazinet A; Karakiewicz PI
Curr Opin Support Palliat Care; 2018 Sep; 12(3):325-333. PubMed ID: 30048250
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
[TBL] [Abstract][Full Text] [Related]
9. Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma.
Carlo MI; Voss MH; Motzer RJ
Nat Rev Urol; 2016 Jul; 13(7):420-31. PubMed ID: 27324121
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy in Metastatic Renal Cell Carcinoma: A Comprehensive Review.
Raman R; Vaena D
Biomed Res Int; 2015; 2015():367354. PubMed ID: 26161397
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Therapy Options in Renal Cell Carcinoma: Where Do We Stand?
Martinez Chanza N; Tripathi A; Harshman LC
Curr Treat Options Oncol; 2019 May; 20(5):44. PubMed ID: 31054006
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy for advanced renal cell carcinoma.
Meissner MA; McCormick BZ; Karam JA; Wood CG
Expert Rev Anticancer Ther; 2018 Jul; 18(7):663-671. PubMed ID: 29707987
[TBL] [Abstract][Full Text] [Related]
13. Checkpoint Blockade - a New Treatment Paradigm in Renal Cell Carcinoma.
Grünwald V
Oncol Res Treat; 2016; 39(6):353-8. PubMed ID: 27259695
[TBL] [Abstract][Full Text] [Related]
14. Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma.
Guislain A; Gadiot J; Kaiser A; Jordanova ES; Broeks A; Sanders J; van Boven H; de Gruijl TD; Haanen JB; Bex A; Blank CU
Cancer Immunol Immunother; 2015 Oct; 64(10):1241-50. PubMed ID: 26105626
[TBL] [Abstract][Full Text] [Related]
15. Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma.
Sfoungaristos S; Giannitsas K; Perimenis P
Expert Opin Pharmacother; 2011 Mar; 12(4):533-47. PubMed ID: 21306289
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy: incorporation in the evolving paradigm of renal cancer management and future prospects.
Liu KG; Gupta S; Goel S
Oncotarget; 2017 Mar; 8(10):17313-17327. PubMed ID: 28061473
[TBL] [Abstract][Full Text] [Related]
17. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.
Korenbaum C; Pierard L; Thiéry A; Story F; Lindner V; Lang H; Kurtz JE; Barthélémy P
Clin Genitourin Cancer; 2018 Jun; 16(3):e577-e586. PubMed ID: 29395949
[TBL] [Abstract][Full Text] [Related]
18. The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications.
Aurilio G; Piva F; Santoni M; Cimadamore A; Sorgentoni G; Lopez-Beltran A; Cheng L; Battelli N; Nolè F; Montironi R
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766196
[TBL] [Abstract][Full Text] [Related]
19. Pazopanib for the treatment of metastatic renal cell carcinoma.
Pick AM; Nystrom KK
Clin Ther; 2012 Mar; 34(3):511-20. PubMed ID: 22341567
[TBL] [Abstract][Full Text] [Related]
20. Current Approaches to the Treatment of Advanced or Metastatic Renal Cell Carcinoma.
Tenold M; Ravi P; Kumar M; Bowman A; Hammers H; Choueiri TK; Lara PN
Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-10. PubMed ID: 32239988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
